Should You Buy F-Star Therapeutics Inc (FSTX) Stock on Wednesday?

Wednesday, February 01, 2023 12:13 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy F-Star Therapeutics Inc (FSTX) Stock on Wednesday?

The market has been down on F-Star Therapeutics Inc (FSTX) stock recently. FSTX gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

F-Star Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on FSTX!

See Full FSTX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With FSTX Stock Today?

F-Star Therapeutics Inc (FSTX) stock has gained 21.65% while the S&P 500 is down -0.54% as of 12:01 PM on Wednesday, Feb 1. FSTX is higher by $0.89 from the previous closing price of $4.11 on volume of 1,293,759 shares. Over the past year the S&P 500 is lower by -10.21% while FSTX is higher by 28.87%. FSTX lost -$2.07 per share in the over the last 12 months.

More About F-Star Therapeutics Inc

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments. Click Here to get the full Stock Report for F-Star Therapeutics Inc stock.